1
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
Condition(s):Primary Breast CancerLast Updated:November 19, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Primary Breast CancerLast Updated:November 19, 2008Completed
Condition(s):Breast CancerLast Updated:June 9, 2009Completed
Condition(s):Breast Cancer; Psychosocial Effects of Cancer and Its Treatment; Sexual Dysfunction and Infertility; Sexuality and Reproductive IssuesLast Updated:October 24, 2013Completed
Condition(s):Breast Cancer Stage II; Breast Cancer Stage IIILast Updated:January 24, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.